Study of Mortality in a Urology Department: A Case of the Urology Department of the Cocody University Hospital

Abstract

Objective: To analyze the rate and the main causes of mortality in the Urology Department of the CHU of Cocody. Patients and Methods: A retrospective study was conducted on 548 patients who died between January 2000 and December 2021 in the Urology Department of Cocody University Hospital. The information was obtained from medical records, hospitalization registers and death certificates, which made it possible to study the frequency and causes of death with the help of Statistical Package for the Social Sciences 16.0 (SPSS). Results: The overall mortality rate was 21.13%. The sex ratio was 12.7 men to 1 woman, with an average age of 65.5 years (21 - 89 years). The causes of death were represented by cancer pathologies (78.10%). Prostate cancer, which was the first reason for consultation, was the first cause of death in 55.66% of cases, followed by bladder cancer, BPH, Fournier gqngrene, kidney cancer, and urethral stricture, cancer of the testicles, with respectively 17.52%, 10.77%, 7.12%, 3.46% and 1.46%. Conclusion: The mortality rate in Urology Department of the CHU of Cocody remains high and is essentially to urological cancers.

Share and Cite:

Kouame, B. , Kramo, F. , Drabo, A. , Amangoia, V. , Coulibaly, I. , Konan, K. and Dekou, A. (2025) Study of Mortality in a Urology Department: A Case of the Urology Department of the Cocody University Hospital. Open Journal of Urology, 15, 456-464. doi: 10.4236/oju.2025.1510047.

1. Introduction

Mortality is the study of deaths and their evolution in a population [1]. Its study in a hospital department allows for a control and revision of therapeutic measures. In the literature, several studies on hospital mortality have been carried out in paediatrics, gynaecology and obstetrics and in infectious disease departments [2].

Relatively few studies have been performed on in-hospital mortality in urology. In Côte d’Ivoire, Dékou et al. had carried out the last study on mortality in urology in 2009 [3].

The aim of this work was to estimate the mortality rate and to identify the main causes of death in urology.

2. Patients and Methods

This was a retrospective descriptive study carried out in the Urology Department of the Cocody University Hospital over a period of 22 years, from January 1, 2000 to December 31, 2021.

The sample consisted only of patients who died during hospitalization in the department during the study period. Data were collected from the hospitalization register, the urology department’s death register, and deceased patient records.

The parameters evaluated were essentially the age and sex of the deceased patients; clinical diagnosis, comorbidity factors, and causes of death. The data analysis was done by SPSS 16.0 software.

3. Result

2593 patients were hospitalized during the study period and 548 deaths were recorded.

3.1. Distribution of Deaths by Year

Table 1. Distribution of patient deaths by year.

Year

Hospitalized

Deceased

Percentage (%)

2000

132

28

21.21

2001

16

3

18.75

2002

34

7

20.59

2003

18

4

22.22

2004

34

7

20.59

2005

130

27

20.77

2006

26

5

19.23

2007

60

13

21.66

2008

26

5

19.23

2009

86

18

20.93

2010

60

13

21.66

2011

111

24

21.62

2012

60

13

21.66

2013

267

56

20.97

2014

407

86

21.13

2015

267

56

20.97

2016

52

11

21.15

2017

70

15

21.43

2018

301

64

21.26

2019

67

14

20.89

2020

52

11

21.15

2021

319

67

21.00

Total

2593

548

21.13

The highest number of deaths was recorded in 2014, with 86 deaths and an overall mortality rate of 21.13% (Table 1).

3.2. Age

The average age of patients who died was 68 years.

Figure 1. Distribution of deceased patients by group of age.

Average age was 65.82 years; Median was 68 years; Standard deviation was 12.714; minimum = 21 years old; maximum = 89 years. Patients aged 51 to 80 years (78.8%) predominated with two peaks in the [61 - 70] and [71 - 80] brackets with 34.8% and 29.5% respectively (Figure 1).

3.3. Sex

Male gender was dominated with sex-ratio of 12.7 males for a female (Figure 2).

Figure 2. Distribution of patients according to sex.

3.4. Comorbidity Factors

Cancer was the first responsible of death in this study (Table 2).

Table 2. Distribution of patients according to comorbidity factors.

Pathology

Numbers

Percentage (%)

Prostate cancer + Hypertension

41

33.06

Benign prostate hyperplasia + hypertension

15

12.09

Bladder cancer + hypertension

30

24.19

Ureteral stricture + HIV

9

7.26

Fournier gangrene + Diabetes

19

15.32

Fournier gangrene + Hiv

103

8.06

Total

124

100

3.5. Mortality per Pathology

Table 3. Distribution of patients according to the cause of death.

Pathology

Numbers of

Deceased

Numbers

Hospitalized

Percentage (%)

Prostate cancer

305

1084

28.14

Penile fracture

0

21

0

Benign prostate hyperplasia

59

575

10.80

Ureteral stricture

19

162

11.72

Kidney abscess

0

13

0

Ectopic testicular

0

4

0

Vescio-vagina fistular

0

8

0

Inguinal hernia

2

4

50

Hydrocele

0

8

0

Renal calculus

0

1

0

Ureteric calculus

1

63

1.59

Fournier gangrene

39

134

29.10

Orchitis

0

56

0

Priapism

0

142

0

Prostatitis

0

16

0

Pyelonephritis

0

4

0

Ureteral stricture

0

8

0

Testicular torsion

0

13

0

Renal tumor

19

92

20.65

Testicular tumor

8

8

100

Bladder tumor

96

178

53.63

Total

548

2593

21.13

Infection disease was represented by Fournier gangrene with 29.10% (Table 3).

3.6. Mortality

Table 4. Distribution of patients according to pathology.

Pathologie

Numbers

Percentage (%)

Rank

Prostate cancer

305

55.66

1

Bladder cancer

96

17.52

2

Benign prostate hyperplasia

59

10.77

3

Fournier gangrene

39

7.12

4

Uretral stenosis

19

3.46

5

Renal tumor

19

3.46

5

Testicular cancer

8

1.46

7

Inguinale hernia

2

0.36

8

Ureteral calculus

1

0.18

9

Total

548

100

Prostate cancer was responsible of the highest rate of mortality. It was followed by bladder cancer (Table 4).

3.7. Mortality Due to Cancerous Pathology

Pathology of cancer was responsible of 78.10% of death (Table 5).

Table 5. Distribution of patients according to cancerous pathology.

Pathology

Numbers

Percentage (%)

Rank

Prostate cancer

305

71.26

1

Bladder cancer

96

22.43

2

Renal cancer

19

4.44

3

Testicular cancer

8

1.87

4

Total

428

100

3.8. Mortality Due to Non-Cancerous Conditions

Non-cancer pathologies were responsible of 21.90% of death (Table 6).

Table 6. Distribution of patients according to non-cancerous condition.

Pathology

Numbers

Percentage (%)

Rank

Benign prostate hyperplasia

59

49.17

1

Fournier gangrene

39

32.5

2

Ureteral stenosis

19

15.83

3

Inguinal hernia

2

1.66

4

Renal calculus

1

0.83

5

Total

120

100

4. Comment

During the study period, 2593 patients were hospitalized and 548 were deceased, i.e., a hospital mortality of 21.13%. Mortality per year showed a high incidence in 2003 of 22.22%.

Siné et al., in Senegal, had observed a hospital mortality of 2.9% over a period of 6 years [4].

Our study period was 20 years, which is more than 3 times the length of Sine et al.’s study period. The long period could explain the difference in hospital mortality. In addition, Côte d’Ivoire experienced the military-political crisis in 2022 and the post-electoral crisis in 2010. During these crises, the dysfunction of health systems, the lack of quality health care workers contributed to the increase in mortality in our study.

The mean age of the patients who died was 65.8 (or 68? to be verified) years.

Siné et al. had found an average age of 63.6 in 2016 in Senegal [4], which was more or less equal to ours.

Takangno et al. had observed an average age of 43 years [5].

Takangno et al.’s study was carried out in a general surgery department where many pathologies develop in subjects before the age of 50. In urology, the majority of pathologies that cause death occur after the age of 50.

The male sex predominated in our study with a sex-ratio of 12.7 men to one woman. Our result was similar to that of Dembélé et al., who had observed a sex ratio of 17.8 men to one woman [6].

Generally speaking, urology departments are more frequented by men. Indeed, urology treats disorders of the urinary and genital tract of men. While for women, it only treats urinary tract conditions. In addition, prostate cancer was the leading cause of death. This pathology is only observed in men.

Comorbidity factors were dominated by hypertensives.

This pathology is becoming more and more common in the general population.

Hamza had observed smoking as the most common comorbidity factor [7].

This difference is due to the fact that Hamza’s study was carried out in Morocco, where the population has a high propensity to consume tobacco, as in other Maghreb countries.

Urogenital cancers were responsible for 78.1% of deaths. Siné et al., in their study, 56% of deaths were due to urological cancer [4]. In Hamza’s study in Morocco, urological cancers were responsible for 60% of deaths [7]. In some developed countries, urogenital cancers were the leading cause of death in urology [8]-[10].

The high mortality of urological cancers in our context could be explained by the fact that diagnosis is usually made at the metastatic stage. Many patients consulted late in our context. Patients only come to hospital if symptoms persist or worsen.

Prostate cancer was the leading cause of death with 71.26%, followed by bladder cancer with 22.43% and kidney cancer with 4.44%. In Senegal, Siné et al. had prostate cancer [4]. In the literature, several studies have observed prostate cancer as the leading cause of death [11] [12].

Non-cancerous conditions were responsible for 18% of deaths. Benign prostatic hyperplasia accounted for 49.17% followed by Fournier gangrene with 32.5%. This result was comparable to that of Siné et al. in Senegal [4].

BPH was the leading cause of hospitalization. It was the leading cause of death from non-cancerous diseases. It was BPH complicated by abundant hematuria with a state of hemorrhagic shock. The unavailability of products, generally due to the impoverishment of the population, caused the death of these patients. This reveals the shortage of blood products in the Ivorian health system.

Sometimes the death was related to ionic disorders (dyskalemia, dysnatremia) caused by obstructive renal insufficiency, which sometimes complicated benign prostatic hyperplasia.

Fournier gangrene was the only cause of death related to infectious diseases. It represented 23%. In Bakayoko’s study, this condition did not cause death. Deaths of infectious origin accounted for 68%, mainly due to urinary phlegmon of the bursa [6].

In the contemporary literature, causes of infectious origin were 68% [13] [14].

Sepsis and subsequently septic shock caused the death of patients. In the emergency departments, due to a lack of good resuscitation, these patients died in the preoperative period.

5. Conclusions

Hospital mortality in our context remains high compared to developed countries. Urological cancers were responsible for more than 70% of cases. Prostate cancer remains the leading cause of death at Urology Department of the CHU of Cocody. Thus, the need to organize screening campaigns for people above 50 years in order to have an early diagnosis of localized prostate cancer. Which have curative treatment.

Though our study was carried out in the largest Urology Department of Côte d’Ivoire, it was a limited fact that there are two of those departments. Thus, there is a need to extend our study.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300.[CrossRef] [PubMed]
[2] Magoha, G.A. (1995) Epidemiology and Clinical Aspect of Incidental Carcinoma of the Prostate in Africans: Experience at the Lagos University Teaching Hospital, Lagos and the Kenyatta National Hospital, Nairobi. East African Medical Journal, 72, 283-287
[3] Dékou, A., Ouegnin, G.A., Konan, P.G., Kouamé, B., Fofana, A., Kramo, N., et al. (2009) Contribution à l’étude de la mortalité dans un service d’urologie: Le cas du service d’urologie du CHU de Cocody d’Abidjan de 2000 à 2006. African Journal of Urology, 15, 44-52.[CrossRef]
[4] Siné, B., et al. (2016) Specific Mortality in Urology in a Reference Hospital in Senegal: Analysis of a Series of 132 Deaths. African Journal of Urology, 22, 329-332.
[5] Dembélé, M. (2014) Mortality in Urology: Identification of the Different Causes during the Last Four Years in the Urology-Andrology Department of the Aristide Le Dantec University Hospital in Dakar. Ph.D. Thesis, Université Félix Houphouët-Boigny.
[6] Takongmo, S., Angwafo, F., Binam, F., Ela, A., Fonkou, A., Gaggini, J., et al. (1993) Hospital Mortality in a Surgical Setting: Need for a Medical Audit. Médecine dAfrique Noire, 40, 729-733.
[7] Hamza, F.B. (2016) Mortality in the Urology Department. Ph.D. Thesis, Sisi Mohamed Ben Abdallah University.
[8] Crawford, E.D. (2003) Epidemiology of Prostate Cancer. Urology, 62, 3-12.[CrossRef] [PubMed]
[9] Giovannucci, E., Rimm, E.B., Ascherio, L., Colditz, G.A., et al. (1999) Smoking and Risk of Total and Fatal of Prostate Cancer in United State Health Professional. Cancer Epidemiology, Biomarkers & Prevention, 84, 227-282.
[10] Grosclaude, P., Belot, A., et al. (2013) Projection of the Incidence and Mortality of Urological Cancer in France in 2012. Progress in Urology, 2, S57-S66.
[11] Echimane, A.K., Ahnoux, A.A., Adoubi, I., Hien, S., M’Bra, K., D’Horpock, A., et al. (2000) Cancer Incidence in Abidjan, Ivory Coast: First Result from the Cancer Regis-try,1995-1997. Cancer, 89, 653-663.[CrossRef]
[12] Grosclaude, P., Belot, A., Daubisse Marliac, L., Remontet, L., Leone, N., Bossard, N., et al. (2015) Prostate Cancer, Evolution of Incidence and Mortality in France between 1980 and 2011. Progrès en Urologie, 25, 536-542.[CrossRef] [PubMed]
[13] Eke, N. (2000) Fournier’s Gangrene: A Review of 1726 Cases. Journal of British Surgery, 87, 718-728.[CrossRef] [PubMed]
[14] Morua, A.G., Lopez, J.A., Garcia, J.D., Montelengo, R.M. and Guerra, L.S. (2009) Fournier’s Gangrene: Our Experience in 5 Years, Bibliographic Review and Assessment of the Fournier’s Gangrene Severity Index. Archivos Españoles de Urología, 62, 532-534.

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.